Pros and Cons to Prostate Surgeries

Study Finds Pro and Cons to Prostate Surgeries By RONI CARYN RABIN Published: October 13, 2009 Prostate cancer patients who chose minimally invasive surgery rather than more extensive operations to remove the prostate were less likely to experience complications like pneumonia, but reported higher rates of long-term problems, including impotence and incontinence, according to one of the largest studies to compare outcomes to date. Patients achieved similar rates of cancer c...

Radiation First, Then Seed Implant

Thursday, January 1, 2004 Radiation First, Then Seed Implant: More Ammunition to Support this Sequence in the Treatment of Prostate Cancer Perhaps the most contested issue in the combination of external beam radiation with radioactive seed implant treatment for prostate cancer has been the order in which the two therapies are delivered. There have been strong opinions on both sides. With the recent publication of "Increased Expression of PSA mRNA During Brachytherapy in Per...

Incurable PCa? Consider Brachytherapy

Saturday, May 1, 2004 Incurable PCa? Consider Brachytherapy Over the past decade, prostate brachytherapy has gained increasing popularity for the treatment of prostate cancer, especially in view of the favorable side-effect profile when compared to alternative therapies. The number of patients treated with this modality is now on par with both radical prostatectomy and full-course external beam radiotherapy (EBRT) as the primary treatment for early stage prostate cancer. Despi...

Next Generation Prostate Ultrasound Studies

Tuesday, June 1, 2004 Next Generation Prostate Ultrasound Studies Debut at Dattoli Cancer Center Accurately diagnosing prostate cancer is essential to successful treatment. The widely used PSA blood test is only an indication of the relative health of the prostate gland, and as recent studies indicate, a low PSA can give a false sense of security to as many as 15% of men reporting them. The walnut-sized gland, deep in the man’s lower abdomen presents physical exam challeng...

Clinical Outcomes Reported at ASTRO

Sunday, October 17, 2004 Clinical Outcomes Reported at ASTRO Demonstrate Effectiveness of Palladium-103 Brachytherapy in Treatment of Aggressive Prostate Cancer BUFORD, Ga., Oct 17, 2002- Theragenics Corporation(R) (NYSE: TGX) announced today the results of new studies confirming the effectiveness of TheraSeed(R), a Palladium-103 (Pd-103) brachytherapy product, in patients with aggressive cancer who previously were considered poor candidates for seeding. The findings, revealed i...